Skip to content

Chinese pharmaceutical and health brand associated with vitamins, dietary supplements, and medicines.

Last updated November 4, 2026

AI crawler reads

4requests

1companies
  • Anthropic4
Profile
2
Controversies
2
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

Hayao, written 哈药 in Chinese, is a Chinese pharmaceutical and health brand associated with vitamins, nutritional supplements, and medicines. The supplied reference material identifies it primarily with vitamin and dietary-supplement products, while the existing dossier describes the business more broadly as a Chinese pharmaceutical and health brand. Its supplied website uses the hayao.com.cn domain, and the brand is associated with Harbin, China. Beyond these basic identifiers, the available material does not establish a reliable corporate chronology, ownership structure, founding date, product catalogue, executive roster, or international operating footprint. The name may refer to a consumer-facing brand connected with the broader Hayao pharmaceutical group or to a corporate identity used across pharmaceutical and health products; the available reference does not resolve that distinction. Accordingly, this entry treats Hayao as a product brand for cataloguing purposes while marking the record for review. The clearest supported positioning is in consumer health, especially vitamins and nutritional supplementation, with pharmaceutical products also within the described scope. No verified information was supplied about specific formulations, named flagship products, product launches, advertising campaigns, acquisitions, regulatory matters, litigation, financial performance, or current leadership. Hayao should therefore not be conflated with unrelated brands or entities that use similar romanizations, and corporate facts should be added only after confirmation from authoritative company, regulatory, exchange, or trade sources.

History

The available reference material provides only a limited basis for reconstructing Hayao's history. It identifies 哈药 as a Chinese pharmaceutical and health name connected with vitamins, dietary supplements, and medicines, and associates the brand with Harbin. The supplied website is hayao.com.cn. No reliable source material in the brief establishes when the name was created, which legal entity first used it, who founded or controlled it, or how its product portfolio developed. The relationship between the Hayao name and any broader pharmaceutical group is also not documented sufficiently to describe as fact. The existing dossier presents Hayao as a Chinese pharmaceutical and health brand rather than as a clearly defined standalone corporation, but that characterization remains provisional. Based on the supported description, Hayao's commercial identity is centered on consumer health. Vitamins and nutritional supplements appear to be the most relevant category for the requested taxonomy, while medicines are also included in the broader product description. There is not enough evidence to identify particular vitamin types, dosage forms, therapeutic indications, packaging systems, manufacturing sites, distribution channels, or geographic markets beyond China. Similarly, the available material does not document a transition from pharmaceutical products into supplements, a major rebranding, a specific product-generation history, or a confirmed expansion outside China. A reliable historical account would require authoritative company records, regulatory registrations, trademark information, official corporate disclosures, or reputable reporting that distinguishes the brand from similarly named companies and product labels. Until that evidence is available, the principal historical conclusion is that Hayao is a Harbin-associated Chinese health and pharmaceutical name with a documented thematic connection to vitamins and nutritional supplementation, but with its legal identity, chronology, and corporate relationships unresolved.

Products and positioning

Consumer health and pharmaceutical products, with an apparent emphasis on vitamins and nutritional supplementation.

  • Vitamins

    Vitamins

    Vitamin products are the clearest category associated with Hayao in the supplied reference material. No specific nutrients, formulations, dosage forms, indications, launch dates, or named sub-brands are documented, so this entry records the category without attributing particular products to the brand.

  • Nutritional supplements

    Dietary supplements

    Hayao is described as being connected with nutritional supplements and consumer health products. The available material does not identify individual supplement lines, ingredients, claims, formats, or sales channels. The category is therefore included as a supported portfolio area rather than as evidence of a specific SKU range.

  • Pharmaceuticals

    Medicines

    The broader description of Hayao includes medicines as part of its pharmaceutical and health scope. No therapeutic classes, prescription status, approved products, manufacturing information, or product history is available in the supplied sources.

Controversies

  • 2011

    Harbin Pharmaceutical General Factory exposed over pollution and apologizes

    Economic Information Daily reported in an investigation that the Harbin Pharmaceutical General Factory had long caused odor nuisance and wastewater discharge problems. The company apologized to the public for excessive emissions and denied some claims that its environmental protection investment was lower than its advertising investment. Progress: media investigation and company response. Entities involved: Harbin Pharmaceutical Group General Pharmaceutical Factory. Scope: Harbin Pharmaceutical Group General Pharmaceutical Factory.

  • 2011

    Harbin Pharmaceutical General Factory pollution exposed: “advertising spend 27 times environmental protection”

    In June 2011, CCTV and other media exposed that the Harbin Pharmaceutical Group General Pharmaceutical Factory had long illegally discharged wastewater, waste gas, and solid waste; nearby residents were severely affected by the stench, and its advertising investment was 27 times its environmental protection investment, causing a public outcry. The Harbin environmental protection authorities subsequently fined it 1.23 million yuan, and the penalty was criticized as “a brickbat.” From 2015 to 2017 it was still continuously included on the key monitoring list. Harbin Pharmaceutical pledged to rectify the problems and invest in pollution control.

  • 2011

    Illegal Drug Ads Exposed More Than a Dozen Times in Six Years

    China News Service reported that Harbin Pharmaceutical's 五海瘿瘤丸, 微达康颗粒, 牛鲜茶 and other products were exposed more than a dozen times within six years for illegal advertising, involving unapproved ads, exaggerated efficacy, absolute claims, and promotion of prescription drugs in mass media; some products were suspended from sale or had their advertising approvals revoked. The company was repeatedly handled by drug regulatory authorities.

Read more

Sources6 sources

Cite this profile: Cite the canonical profile. /brand-wiki/哈药 · Editorial policy · How profiles are compiled